Search results for:
artesunate
artesunate
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Artesunate |
POWDER FOR INJECTION, INTRAVENOUS |
110 mg |
|
|
|
|
Last updated: Feb. 3, 2025
- HAZ-MED: Table 2R
- Formulary, Not Routinely Stocked: 110 mg
Formulary, not routinely stocked, restricted to infectious diseases for initiation of therapy for patients with severe malaria with laboratory evidence of severe disease and/or major signs of organ dysfunction (i.e. altered consciousness, seizures, respiratory distress/ARDS, renal failure, jaundice, DIC, severe anemia, hypoglycemia, circulatory dysfunction, others) and not able to take oral medication.
Interim treatment with an effective oral antimalarial agent [artemether-lumefantrine (COARTEM)] should be started as soon as possible.
Reviewed: Oct. 2021